Is that something likely to happen? I think the company will be looking forward to delivering their EOY P&L, it's likely to look really strong, exceeding all budget expectations. To date their sales are great and their margin GP is great as well. Add to that their recent deal with Priceline and they now have the expanded platform to expose more product to more people.
That's without even talking about their commitment to clinical based supplements that actually work. Again, their approach to medicine is really exciting.
These views are my own of course.
Is that something likely to happen? I think the company will be...
Add BIO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
53.0¢ |
Change
0.020(3.92%) |
Mkt cap ! $118.4M | |||
| Open | High | Low | Value | Volume |
| 53.5¢ | 55.0¢ | 53.0¢ | $294.5K | 545.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 23779 | 53.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 53.5¢ | 6500 | 1 |
View Market Depth
| Last trade - 11.57am 01/08/2024 (20 minute delay) ? |
| BIO (ASX) Chart |